Datwin, Ariannah Mae L.
HRN: 22-97-94 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/20/2023
07/26/2023
IVTT
115mg
Q24h
PCAP C
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes